Shares of AbbVie (NYSE:ABBV) currently trade at just over nine times expected earnings. To put that into perspective, the forward earnings multiple for the S&P 500 stands above 21 right now. Healthcare stocks, on average, trade at more than 16 times expected earnings. Another big drugmaker, Bristol Myers Squibb (NYSE:BMY), sports an even more appealing valuation than AbbVie does. BMS stock trades at under 8.9 times expected earnings. You'll have a hard time finding a dividend stock that's cheaper than Viatris (NASDAQ:VTRS). Its shares trade at only 4.3 times expected earnings.
Source: Motley Fool
Related Articles:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.